DXC: Post Collapse Recovery detected on 20 Jul 2026

DXC is forming a post-collapse recovery pattern after FY26 revenue declined 1.8% YoY (organic down 4.8%). The stock trades at $9.47 with structure score of 14.8 and volume score of 12.0 (out of respective maxima 15 and 12), signaling solid pattern construction. Key resistance sits at $10.75 while support anchors at $7.93—a 39.6% drop from 52-week highs reflects the collapse phase. The breakout score of 8.41 is moderate; volume ratio of 0.56x average suggests participation below normal but acceptable given recovery stage. Ascending triangle and bullish pennant patterns formed in June (33.5 and 31.0 quality scores) preceded this setup. Overall score of 71.21 indicates above-average technical merit.

Q3 FY26 delivered diluted EPS of $0.61 (up 96.8% YoY) with non-GAAP EPS of $0.96 (up 4.3% YoY), bookings of $3.6B at 1.12x book-to-bill, and adjusted EBIT margin of 8.2%. Management cited solid profit margins, strong free cash flow, and improved bookings while investing in Core business and Fast Track solutions for future revenue growth. DXC was named to Fortune's America's Most Innovative Companies 2026, citing emphasis on operationalizing AI including Xponential, Human+, and three new AI centers. A June 11, 2026 Investor Day featured strategy discussion on capitalizing on accelerating AI adoption, with CEO Raul Fernandez presenting AI-enabled solutions. DXC announced alliance with Anthropic as Global Premier partner in Claude Partner Network for new AI offerings. These catalysts—profitability improvement, AI transformation narrative, and partnership strength—coincide with the price recovery structure.

A successful breakout would clear the $10.75 resistance level with the measured move target of $9.95 (conservative estimate) as the initial objective. Win probability of 68.26% reflects above-average historical success. Volume confirmation would require relative volume approaching the 20-day average (currently 0.56x at 3.26M shares); sustained breakout volume above 5.8M shares would validate upside pressure. The invalidation level anchors at $7.93 support—a close below this price would signal pattern failure and likely reversion to deeper selling. Given RSI of 51.76 (neutral zone), momentum is not yet overbought, leaving room for accumulation into breakout.

Organic revenue decline of 4.8% YoY signals ongoing structural headwinds in core business despite margin improvements. The technology sector regime is bearish (regime score -0.35), conflicting with bullish market regime (0.54), creating cross-currents. Volume ratio of 0.56x average indicates weak participation—if institutional buying does not accelerate, the pattern may stall at resistance. Beta of 1.37 exposes this mid-cap to 37% greater volatility than broader market; a 25% loss in three months already occurred. Recent 2-week performance of -4.44% and absence of near-term earnings catalysts (last reported May 7, 2026) mean announcement surprises could disrupt the setup. Watch for any revision of AI monetization guidance at upcoming investor communications.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.